Self-experimentation in snake venom research reveals systemic gaps in global antivenom access and ethical oversight

Indigenous communities in snake-rich regions possess centuries of empirical knowledge on snake behavior, bite prevention, and traditional first aid, yet this knowledge is systematically excluded from formal antivenom research and policy. The Irula community in India, for example, has supplied venom to antivenom producers for decades without benefit-sharing agreements or co-authorship in scientific publications. Traditional healers in Nigeria and Ghana use plant-based treatments that show promise in neutralizing certain snake toxins, but these are marginalized in favor of Western pharmaceutical models. The erasure of this knowledge reflects a broader pattern of epistemic injustice in global health.

Colonial-era scientific expeditions systematically collected venomous snakes and traditional knowledge from colonized regions without consent, laying the foundation for modern antivenom production. The 19th-century British Empire's medical research in India prioritized venom extraction for European laboratories over local health needs, a pattern that persists today in the global health research agenda. The current antivenom shortage echoes historical failures to invest in regional production hubs, despite the 1978 Alma-Ata Declaration calling for primary healthcare in endemic regions. The focus on self-experimentation reflects a continuity of individualistic Western scientific heroism narratives that obscure systemic failures.

In Australia, Aboriginal ranger programs integrate traditional ecological knowledge with modern conservation to reduce human-snake conflict, demonstrating a cross-cultural model for coexistence. Brazilian 'serpentários' (snake farms) operated by traditional healers supply venom to antivenom producers while maintaining cultural practices, contrasting with Western laboratory-based models. In Papua New Guinea, community-led snakebite response teams combine traditional first aid with modern training, achieving lower mortality rates than in regions reliant solely on imported antivenom. These models highlight the potential of integrating diverse knowledge systems to address snakebite holistically.

Snakebite envenoming is a neglected tropical disease affecting 5.4 million people annually, with 138,000 deaths and 400,000 disabilities, yet receives less than 0.01% of global health funding. The World Health Organization's 2019 Snakebite Envenoming Strategy emphasizes community-based prevention and regional antivenom production, yet implementation lags due to funding gaps and pharmaceutical industry disincentives. Self-experimentation, while yielding valuable data, cannot replicate the complex ecological and social factors influencing snakebite incidence. Emerging research on venom-derived peptides for drug development (e.g., Captopril from Bothrops jararaca venom) underscores the scientific value of venom biodiversity but requires ethical frameworks for equitable benefit-sharing.

In Hindu traditions, snakes are revered as divine entities (e.g., Shesha, Vasuki) and associated with healing deities like Dhanvantari, yet this spiritual connection is rarely integrated into modern medical approaches to snakebite. Australian Aboriginal art often depicts snakes as ancestral beings, reflecting ecological wisdom that could inform conservation and public health messaging. In West African Vodun traditions, snakes symbolize both danger and protection, with healers using rhythmic drumming and plant-based rituals alongside physical treatments—a holistic approach absent in Western biomedicine. The artistic depiction of snakes in media often reinforces fear, obscuring their ecological role and the cultural significance of human-snake coexistence.

Climate change is projected to expand the range of venomous snakes by 2050, increasing envenoming risk in previously unaffected regions, yet adaptation strategies remain underfunded. The rise of 'precision antivenom' using monoclonal antibodies could revolutionize treatment but risks exacerbating inequities if priced out of reach for endemic regions. Community-based early warning systems, combining traditional ecological knowledge with IoT sensors, could reduce human-snake conflict in high-risk areas. The integration of Indigenous knowledge into antivenom research could accelerate discovery while ensuring equitable benefit-sharing, but requires structural changes in funding and publication norms.

Rural farmers, miners, and children in Sub-Saharan Africa and South Asia bear the brunt of snakebite envenoming, yet their voices are absent from global health policy discussions. Women in these regions, who often lack access to healthcare, face higher mortality rates due to delayed treatment-seeking behaviors influenced by gender norms. Indigenous and tribal communities, despite their expertise, are excluded from antivenom research governance and funding decisions. The focus on Western self-experimentation narratives further marginalizes the lived experiences of those most affected by snakebite, reinforcing a cycle of epistemic and material injustice.